U.S. Department of Health and Human Services partners with Regeneron Pharmaceuticals Inc to develop coronavirus therapy

The U.S. Department of Health and Human Services has partnered with Regeneron Pharmaceuticals Inc to develop a treatment for the coronavirus whose outbreak in China has killed hundreds of people in China alone. The drugmaker collaboration with the U.S. Department of Health and Human Services is the latest to join the race to develop a…

Roche increase gene therapy footprint with $1.5 billion licensing deal with Sarepta Therapeutics

On Monday, in a statement Roche said, it has entered into a $1.15 billion licensing deal with Sarepta Therapeutics to obtain the right to launch and commercialize Sarepta’s investigational gene therapy for Duchenne muscular dystrophy (DMD) outside the United States. Roche will be making an upfront payment of $750 million in cash and $400 million…